Post-approval studies (Phase 4)WithdrawnNCT02069886
What this trial is testing
Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia
Who this might be right for
Thalassemia (Transfusion Delendent)
Novartis Pharmaceuticals